Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators

Objectives Differences in gut bacteria have been described in several autoimmune disorders. In this exploratory pilot study, we compared gut bacteria in patients with multiple sclerosis and healthy controls and evaluated the influence of glatiramer acetate and vitamin D treatment on the microbiota....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of investigative medicine Jg. 63; H. 5; S. 729 - 734
Hauptverfasser:	Cantarel, Brandi L., Waubant, Emmanuelle, Chehoud, Christel, Kuczynski, Justin, DeSantis, Todd Z., Warrington, Janet, Venkatesan, Arun, Fraser, Claire M., Mowry, Ellen M.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Los Angeles, CA SAGE Publications 01.06.2015
Schlagworte:	Adjuvants, Immunologic - pharmacology Adjuvants, Immunologic - therapeutic use Adult Cholecalciferol - pharmacology Cholecalciferol - therapeutic use Dietary Supplements Female Gastrointestinal Microbiome - drug effects Gastrointestinal Microbiome - physiology Glatiramer Acetate - pharmacology Glatiramer Acetate - therapeutic use Humans Immunologic Factors - pharmacology Immunologic Factors - therapeutic use Middle Aged Multiple Sclerosis, Relapsing-Remitting - diagnosis Multiple Sclerosis, Relapsing-Remitting - drug therapy Pilot Projects gut microbiome autoimmunity glatiramer acetate multiple sclerosis vitamin D
ISSN:	1081-5589, 1708-8267
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!